- HMNC Brain Health raises $50M Series B to advance two depression drugsHMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German drugmaker Medice led the Series B, wh…Endpoints · 1mo ago↗ source
- Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and moreWelcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking to profile 20 scientists, executives, founders and other enterprisi…Endpoints · 1mo ago↗ source
- Merck brings Welireg-Keytruda combo to treat kidney cancerMerck’s Welireg and Keytruda combination won approval as an adjuvant treatment for kidney cancer patients after surgery to remove all or part of the organ. The combination was approved Friday for…